Cargando…
Correction: Autotaxin inhibitor IOA-289 reduces gastrointestinal cancer progression in preclinical models
| Autores principales: | , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10436453/ https://www.ncbi.nlm.nih.gov/pubmed/37596687 http://dx.doi.org/10.1186/s13046-023-02797-9 |
| _version_ | 1785092327928233984 |
|---|---|
| author | Centonze, Matteo Di Conza, Giusy Lahn, Michael Fabregat, Isabel Dituri, Francesco Gigante, Isabella Serino, Grazia Scialpi, Rosanna Carrieri, Livianna Negro, Roberto Pizzuto, Elena Giannelli, Gianluigi |
| author_facet | Centonze, Matteo Di Conza, Giusy Lahn, Michael Fabregat, Isabel Dituri, Francesco Gigante, Isabella Serino, Grazia Scialpi, Rosanna Carrieri, Livianna Negro, Roberto Pizzuto, Elena Giannelli, Gianluigi |
| author_sort | Centonze, Matteo |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10436453 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104364532023-08-19 Correction: Autotaxin inhibitor IOA-289 reduces gastrointestinal cancer progression in preclinical models Centonze, Matteo Di Conza, Giusy Lahn, Michael Fabregat, Isabel Dituri, Francesco Gigante, Isabella Serino, Grazia Scialpi, Rosanna Carrieri, Livianna Negro, Roberto Pizzuto, Elena Giannelli, Gianluigi J Exp Clin Cancer Res Correction BioMed Central 2023-08-18 /pmc/articles/PMC10436453/ /pubmed/37596687 http://dx.doi.org/10.1186/s13046-023-02797-9 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
| spellingShingle | Correction Centonze, Matteo Di Conza, Giusy Lahn, Michael Fabregat, Isabel Dituri, Francesco Gigante, Isabella Serino, Grazia Scialpi, Rosanna Carrieri, Livianna Negro, Roberto Pizzuto, Elena Giannelli, Gianluigi Correction: Autotaxin inhibitor IOA-289 reduces gastrointestinal cancer progression in preclinical models |
| title | Correction: Autotaxin inhibitor IOA-289 reduces gastrointestinal cancer progression in preclinical models |
| title_full | Correction: Autotaxin inhibitor IOA-289 reduces gastrointestinal cancer progression in preclinical models |
| title_fullStr | Correction: Autotaxin inhibitor IOA-289 reduces gastrointestinal cancer progression in preclinical models |
| title_full_unstemmed | Correction: Autotaxin inhibitor IOA-289 reduces gastrointestinal cancer progression in preclinical models |
| title_short | Correction: Autotaxin inhibitor IOA-289 reduces gastrointestinal cancer progression in preclinical models |
| title_sort | correction: autotaxin inhibitor ioa-289 reduces gastrointestinal cancer progression in preclinical models |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10436453/ https://www.ncbi.nlm.nih.gov/pubmed/37596687 http://dx.doi.org/10.1186/s13046-023-02797-9 |
| work_keys_str_mv | AT centonzematteo correctionautotaxininhibitorioa289reducesgastrointestinalcancerprogressioninpreclinicalmodels AT diconzagiusy correctionautotaxininhibitorioa289reducesgastrointestinalcancerprogressioninpreclinicalmodels AT lahnmichael correctionautotaxininhibitorioa289reducesgastrointestinalcancerprogressioninpreclinicalmodels AT fabregatisabel correctionautotaxininhibitorioa289reducesgastrointestinalcancerprogressioninpreclinicalmodels AT diturifrancesco correctionautotaxininhibitorioa289reducesgastrointestinalcancerprogressioninpreclinicalmodels AT giganteisabella correctionautotaxininhibitorioa289reducesgastrointestinalcancerprogressioninpreclinicalmodels AT serinograzia correctionautotaxininhibitorioa289reducesgastrointestinalcancerprogressioninpreclinicalmodels AT scialpirosanna correctionautotaxininhibitorioa289reducesgastrointestinalcancerprogressioninpreclinicalmodels AT carrierilivianna correctionautotaxininhibitorioa289reducesgastrointestinalcancerprogressioninpreclinicalmodels AT negroroberto correctionautotaxininhibitorioa289reducesgastrointestinalcancerprogressioninpreclinicalmodels AT pizzutoelena correctionautotaxininhibitorioa289reducesgastrointestinalcancerprogressioninpreclinicalmodels AT giannelligianluigi correctionautotaxininhibitorioa289reducesgastrointestinalcancerprogressioninpreclinicalmodels |